Skip to content

Evaluating the Immunity-Enhancing Potential of Chitrakaharitaki and Brahma Rasayana in Allergic Rhinitis: A Randomized Clinical Trial

A Randomized Comparative Clinical Trial For Evaluation of Urjaskara (Immune Enhancer) Effect of Chitrakaharitaki & Brahmarasayana in the Management of Anurajatajanya Pratishyaya With Special Reference To Allergic Rhinitis - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/098122
Enrollment
70
Registered
2025-11-26
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

None listed

Sponsors

National Institute Of Ayurveda Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Anurjatajanya Pratishyaya (Allergic rhinitis).

Exclusion criteria

Exclusion criteria: 1.Acute conditions of allergic asthma attacks, COPD, TB and interstitial lung disease. 2. Pregnancy/lactation. 3. Severe systemic illnesses like DM, HTN, HIV etc

Design outcomes

Primary

MeasureTime frame
1. Assessment of the Urjaskara (immune-enhancing) effect of Chitrakaharitaki and Brahma Rasayana evaluated using a structured proforma specifically designed based on the classical characteristics of Rasayana effects. 2. Change in serum IgE levels measured before and after the intervention. Timepoint: 60 days

Secondary

MeasureTime frame
Improvement in the clinical features of Anurjatajanya Pratishyaya assessed using a symptom scoring scale.Timepoint: 60 days

Countries

India

Contacts

Public ContactProf Nisha Gupta

National Institute Of Ayurveda Jaipur

guptadr.nisha@gmail.com9828087640

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026